Rare-disease therapeutics company with patient support programs
Keenova pairs pharmaceutical products with direct patient support, operating across manufacturing, quality, and clinical development. The hiring mix—dominated by interns and entry-level roles in sales and marketing, paired with specialized leadership in clinical development, drug quality, and benefits—reflects a scaling commercial operation behind newly launched or expanding therapeutic programs. Active projects around finance transformation, payroll modernization, and Japan market localization signal operational maturation in a mid-market biotech moving beyond pure R&D into global distribution and back-office efficiency.
Notable leadership hires: Clinical Development Director, Benefits Director, Drug Quality Director
Keenova is a public therapeutics company focused on rare and unaddressed conditions, combining drug development with patient-support infrastructure. Based in Dublin with 1,001–5,000 employees, the company operates manufacturing, quality assurance, and clinical development functions alongside commercial sales and marketing teams. Their tech stack centers on Veeva (industry-standard CRM for pharma), SAP/Oracle for ERP, and Workday/ADP for HR and payroll—typical enterprise-scale pharma infrastructure. Current operational priorities include CGMP compliance, treatment-access programs, payroll modernization, and expansion into Japanese markets.
Keenova uses Veeva CRM (pharma-specific), SAP and Oracle for ERP, Workday and ADP for HR/payroll, and Power BI for analytics. Microsoft Office, SharePoint, and GitHub Copilot support back-office and development work.
Dublin, Ireland. The company is a public entity with 1,001–5,000 employees and hiring activity in both Ireland and the United States.
Other companies in the same industry, closest in size